Clue to ending chronic itching side effect of certain drugs discovered
February 9th, 2011 - 5:46 pm ICT by ANIWashington, Feb 9 (ANI): Scientists have identified two distinct neuronal signaling pathways activated by a topical cream used to treat a variety of skin diseases-one pathway produces the therapeutic benefit and the other induces severe itching as a side effect.
The study by a team of researchers from the University of California, San Diego School of Medicine and three South Korean institutions has pointed to the possibility of designing future drugs that effectively treat targeted conditions while blocking the cellular signals that can lead to problematic itching and scratching.
“This new pathway provides another avenue to block the scratching response that appears as a chronic side effect during treatments of cancer, renal failure or the use of some antibiotics,” said Melvin I. Simon, of the UCSD Department of Pharmacology and a corresponding co-author of the study, headed by Sang-Kyou Han, if the UC San Diego.
Simon said that improving understanding of itch biology isn’t just a matter of scratching an intellectual curiosity. It could lead to practical medical benefits, according to.
“Itching and scratching are side effects of a variety of therapeutic drugs and of specific illnesses. In many cases, these effects are severe and make it impossible to use otherwise effective therapies. Thus, the itch remains an unmet medical need,” he said.
In the PNAS study, the scientists focused on Imiquimod (marketed as Aldara), a prescription-based topical cream used to treat a number of skin diseases, including some forms of skin cancer, by activating the body’s innate immune response. One major side effect: Imiquimod produces intense itching and scratching.
The researchers discovered that the skin sensory circuit activated by Imiquimod to causes itching is different from the signaling pathway involved in the drug’s therapeutic benefit. Indeed, the Imiquimod itch mechanism is distinct from other, well-defined itch mechanisms.
The findings have been published in the journal Proceedings of the National Academy of Sciences. (ANI)
- New signaling pathway linked to inflammatory disease discovered - Dec 15, 2010
- New path discovered for colon cancer drug discovery - Nov 20, 2010
- Arsenic-based agent shuts down hard-to-treat cancers - Dec 23, 2010
- Burning pain, itching linked to same nerve cells - Nov 05, 2010
- Breast milk, coconut oil-based face cream may help treat acne - Apr 17, 2010
- Some nerve cells that make us itch also make us feel pain, finds study - May 03, 2011
- Pain and itch are rooted in different molecular mechanisms - Nov 18, 2008
- New discovery opens up novel strategy for combating malaria - Mar 09, 2011
- Love to scratch your back? Here's why - Jan 29, 2012
- Major shift in understanding how eczema develops - Dec 18, 2010
- Topical treatments offer effective local pain relief - Jun 16, 2010
- Factor boosting leukemia's aggressiveness identified - Oct 23, 2010
- 1 drug, many targets may be the future of healing! - Apr 29, 2011
- Broccoli and brussels sprouts boost sunscreens' cancer fighting abilities - Apr 27, 2011
- Coconut oil and nano-bombs may help treat acne - Apr 15, 2010
Tags: california san diego, cellular signals, forms of skin cancer, future drugs, imiquimod, innate immune response, intellectual curiosity, korean institutions, renal failure, sensory circuit, severe itching, signaling pathways, skin diseases, therapeutic benefit, therapeutic drugs, topical cream, uc san diego, ucsd department, university of california san diego, unmet medical need